Happify health and Almirall go live with digital solution to support psoriasis patients by Tracy Williams June 16, 2022 June 16, 2022 Today, Happify Health, the Intelligent Healing Company™, and Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, announced that Claro, a digital program developed via the innovative partnership of both companies, is live and now available to people with psoriasis in Spain, Italy and the United Kingdom. Claro was built to improve the mental well-being of people with psoriasis through cognitive behavioral therapy, positive psychology, and mindfulness. Psoriasis is one of the world’s most prevalent skin diseases, affecting about 60 million people worldwide2. A 2019 study in Maedica, a Journal of Clinical Medicine, establishes a clear link between skin psychology and quality of life for people with psoriasis4. It is estimated that 20% to 30% of people, globally, with moderate to severe psoriasis also suffer from mental health issues, like anxiety and depression1. Approximately 80% of those affected with psoriasis have mild to moderate symptoms, with direct healthcare costs for treatment of psoriasis exceeding $65 billion annually3. “At Almirall, we are proud to offer psoriasis patients a wide range of medicines that cover the whole spectrum of the disease, from mild to severe. Claro helps us to fulfill our commitment to people living with psoriasis, providing them with an enhanced solution addressed to their wellbeing, so they can get their lives back,” said Dr. Volker Koscielny, MD, Chief Medical Officer of Almirall. “Psoriasis is a significant burden in the daily life of 71% of people who suffer from it, according to the National Psoriasis Foundation in the U.K.3,” said Theo Ahadome, Senior Vice President of Commercialization at Happify Health. “We are very pleased with the level of engagement we are seeing so far among Claro users, and this partnership gives us the opportunity to study how effective digital programs are at keeping psoriasis patients engaged during treatment for psoriasis and improving their quality of life.” Almirall S.A.Happify Health Share 0 FacebookTwitterPinterestEmail Tracy Williams previous post Tipping point’ reached as public say they prefer health apps to antidepressants to support mental health conditions next post Dementia Management Tool “Vera” Launches on Apple’s AppStore You may also like Stairlift Expert Gives Advice For 2022 Energy Crisis December 13, 2022 GPs to be able to offer patients ‘digital pill’ for mental health November 29, 2022 Integration of App for Smart Phones gives NHS authority added resilience and... November 21, 2022 Best sleep-boosting foods, plus new study reveals how Brits sleep November 8, 2022 How secure video sharing is improving how clinical teams diagnose, manage and... September 29, 2022 London teens to get preventative mental health support through digital therapeutic app September 19, 2022 Breakthrough Parkinson’s technology moves to next stage in NICE evaluation September 19, 2022 Certific and PocDoc to tackle cardiovascular disease globally with remote monitoring September 6, 2022 UK’s leading digital care technology service sees huge results for social care... August 19, 2022 Xrai Glass: Revolutionary new glasses allow deaf people and people who have... August 16, 2022 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.